These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 8067121)

  • 1. [An evaluation of the protective activity of a multicomponent vaccine made from opportunistic microorganisms in the oral method of immunization in a model of local staphylococcal infection].
    Efremov VN; Poliachenko VM
    Zh Mikrobiol Epidemiol Immunobiol; 1993; (4):73-6. PubMed ID: 8067121
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The protective activity of a multicomponent vaccine made from the antigens of opportunistic microorganisms when administered orally].
    Egorova NB; Mansurova NL; Kuz'mina LA; Kaverina KG
    Zh Mikrobiol Epidemiol Immunobiol; 1993; (1):48-51. PubMed ID: 8067073
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The antigen-specific activity of a multicomponent vaccine administered orally and subcutaneously].
    Mansurova NL; Chuprinina RP; Egorova NB; Kuz'mina LA; Skorikova IG; Kaverina KG
    Zh Mikrobiol Epidemiol Immunobiol; 1995; (1):37-9. PubMed ID: 7539974
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The results of experimental and clinical studies of a multicomponent vaccine made of the antigens from opportunistic microorganisms].
    Egorova NB; Efremova VN; Kurbatova EA; Kuz'mina LA
    Zh Mikrobiol Epidemiol Immunobiol; 1997; (6):96-101. PubMed ID: 9460881
    [No Abstract]   [Full Text] [Related]  

  • 5. [The antigenic activity of vaccines made from opportunistic microorganisms in an experiment to immunize animals by oral and combined methods].
    Efremova VN; Poliachenko VM; Kaverina KG
    Zh Mikrobiol Epidemiol Immunobiol; 1992 Feb; (2):40-3. PubMed ID: 1441812
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Protective activity of a cell-free Klebsiella vaccine in infection in mice caused by Streptococcus pneumoniae serotypes].
    Kurbatova EA; Egorova NB; Krasnoproshina LI; Rodionychev EA; Mansurova NL
    Zh Mikrobiol Epidemiol Immunobiol; 1985 Feb; (2):60-5. PubMed ID: 3887815
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The specific activity of a multicomponent vaccine made from the antigens of opportunistic microorganisms].
    Mansurova NL; Egorova NB; Kaverina KG; Poliachenko VM; Lobova EA
    Zh Mikrobiol Epidemiol Immunobiol; 1991 Apr; (4):39-41. PubMed ID: 1882605
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Immunovac-VP4 vaccine used in complex allergen-specific immunotherapy of patients with hay fever].
    Poddubikova AM; Kostinov MP
    Zh Mikrobiol Epidemiol Immunobiol; 2010; (4):44-8. PubMed ID: 20799399
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The mutagenicity of a new multicomponent vaccine made from the antigens of Klebsiella pneumoniae, Staphylococcus aureus, Proteus vulgaris and Escherichia coli].
    Volgareva GM; Tolcheev IuD; Egorova NB; Mansurova NL; Silin AM; Anpilogova OR
    Zh Mikrobiol Epidemiol Immunobiol; 1991 Jun; (6):50-2. PubMed ID: 1887711
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Use of therapeutic polycomponent vaccine "Immunovac VP-4" for the treatment of chronic bacterial prostatitis].
    Bondarenko VM; Vershinin AE; Kucherskiĭ VM; Mitkov VG; Klimova NE; Kurbatova EA; Egorova NB
    Zh Mikrobiol Epidemiol Immunobiol; 2004; (3):39-43. PubMed ID: 15346948
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Experimental study of the immunogenicity of a monopreparation of Klebsiella pneumoniae antigen complex and its association with Staphylococcus, Proteus and Escherichia coli antigens].
    Egorova NB; Mansurova NL; Kurbatova EA; Efremova VN; Kreĭnin LS
    Zh Mikrobiol Epidemiol Immunobiol; 1984 Jan; (1):35-8. PubMed ID: 6367319
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [ChemicaL and immunochemical characteristics of antigenic preparations from Staphylococcus aureus and Klebsiella pneumoniae as the components for an associated vaccine].
    Shagam NL; Efremova VN; Kurbatova EA; Kaverina KG
    Zh Mikrobiol Epidemiol Immunobiol; 1988 Jun; (6):51-5. PubMed ID: 3140544
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Immunostimulating activity of combined antigens of Klebsiella pneumoniae, Staphylococcus, Proteus and Escherichia coli and separate components in cross infection].
    Egorova NB; Kreĭnin LS; Efremova VN; Kaverina KG; Mansurova NL
    Zh Mikrobiol Epidemiol Immunobiol; 1985 Sep; (9):70-4. PubMed ID: 3907218
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Proteus peritonitis-bacteremia in mice--a model for studying postvaccinal Proteus immunity].
    Zaĭtsev EV; Levina LA
    Zh Mikrobiol Epidemiol Immunobiol; 1990 Jul; (7):74-8. PubMed ID: 2251896
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Naso-subcutaneous application of the polycomponent vaccine VP-4 for the treatment of patients with bronchial asthma and chronic obstructive bronchitis].
    Antonova LP; Markova TP; Kurbatova EA
    Zh Mikrobiol Epidemiol Immunobiol; 2004; (6):36-40. PubMed ID: 15636137
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Preventive properties of the blood sera from persons vaccinated with a Proteus vaccine made from soluble antigen complexes].
    Levina LA; Kreĭnin LS; Kaverina KG; Zdanovskaia LK; Iurova VA
    Zh Mikrobiol Epidemiol Immunobiol; 1986 Apr; (4):84-8. PubMed ID: 3087123
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Protective properties of Proteus ribosomal vaccine].
    Ovetchin PV; Tsyganenko AIa
    Zh Mikrobiol Epidemiol Immunobiol; 1984 Jan; (1):19-23. PubMed ID: 6367317
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The immunogenicity of mono- and associated vaccines made from strains of opportunistic bacteria].
    Soboleva SV
    Zh Mikrobiol Epidemiol Immunobiol; 1991 Oct; (10):31-4. PubMed ID: 1801485
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Immunological activity of a Proteus vaccine administered to volunteers simultaneously with a pyoimmunogen and adsorbed staphylococcal anatoxin].
    Levina LA; Iurova VA; Kreĭnin LS; Kaverina KG; Dubova VG
    Zh Mikrobiol Epidemiol Immunobiol; 1987 Dec; (12):57-61. PubMed ID: 3128030
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Protective efficacy of combined administration of the multicomponent vaccine and the immunomodulator myelopid in experimental infections in mice].
    Stepanenko RN; Egorova NB; Kurbatova EA; Efremova VN; Kuz'mina LA; Skoptsova SV; Novikova EM; Kondarshova MM; Gruber IM
    Zh Mikrobiol Epidemiol Immunobiol; 2000; (5):48-52. PubMed ID: 11220965
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.